Literature DB >> 24526143

Patient selection for advanced heart failure therapy referral.

Alexander C Fanaroff1, Adam D DeVore, Robert J Mentz, Mani A Daneshmand, Chetan B Patel.   

Abstract

Despite advances in medical therapy for chronic heart failure (HF), advanced HF carries a dismal prognosis. Options such as transplantation and durable mechanical circulatory support have greatly improved outcomes for these patients, but their introduction has introduced significant complexity to patient management. Although much of this management occurs at specialized heart transplant centers, it is the responsibility of the primary cardiologist of the patient with advanced HF to refer patients at the appropriate time and to help them navigate the difficult decisions related to the pursuit of advanced therapies. We present a unique pathway that incorporates guidelines, recent data, and expert opinion to help general cardiologists determine which patients should be referred for transplantation or durable mechanical circulatory support, and when they should be referred. Decision making on referral to the heart transplant center is also summarized.

Entities:  

Mesh:

Year:  2014        PMID: 24526143      PMCID: PMC4160660          DOI: 10.1097/HPC.0000000000000004

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  38 in total

Review 1.  Selection of cardiac transplantation candidates in 2010.

Authors:  Donna Mancini; Katherine Lietz
Journal:  Circulation       Date:  2010-07-13       Impact factor: 29.690

2.  The association between blood pressure and mortality in patients with heart failure.

Authors:  Tobias T Lee; Jersey Chen; David J Cohen; Lana Tsao
Journal:  Am Heart J       Date:  2006-01       Impact factor: 4.749

3.  Medical therapy for symptomatic heart failure: a contemporary treatment algorithm.

Authors:  Stephanie M Coronel; Mori J Krantz
Journal:  Crit Pathw Cardiol       Date:  2007-03

4.  2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

5.  Outcomes with an alternate list strategy for heart transplantation.

Authors:  G Michael Felker; Carmelo A Milano; Jonathan E E Yager; Adrian F Hernandez; Laura Blue; Michael B Higginbotham; Andrew J Lodge; Stuart D Russell
Journal:  J Heart Lung Transplant       Date:  2005-08-08       Impact factor: 10.247

6.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

7.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2010-01       Impact factor: 10.247

8.  Summary health status measures in advanced heart failure: relationship to clinical variables and outcome.

Authors:  Mark D Sullivan; Wayne C Levy; Joan E Russo; Barbara Crane; John A Spertus
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

9.  Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.

Authors:  Joseph G Rogers; Javed Butler; Steven L Lansman; Alan Gass; Peer M Portner; Michael K Pasque; Richard N Pierson
Journal:  J Am Coll Cardiol       Date:  2007-08-06       Impact factor: 24.094

10.  Validation of Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy.

Authors:  François Regoli; Francesca Scopigni; Francisco Leyva; Maurizio Landolina; Stefano Ghio; Massimo Tritto; Leonardo Calò; Catherine Klersy; Angelo Auricchio
Journal:  Eur J Heart Fail       Date:  2012-10-30       Impact factor: 15.534

View more
  4 in total

Review 1.  Systematizing Heart Failure Population Health.

Authors:  Prateeti Khazanie; Larry A Allen
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

2.  Determining the factors for interhospital transfer in advanced heart failure cases.

Authors:  Koichi Narita; Eisuke Amiya; Masaru Hatano; Junichi Ishida; Shun Minatsuki; Masaki Tsuji; Chie Bujo; Nobutaka Kakuda; Yoshitaka Isotani; Minoru Ono; Issei Komuro
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-14

Review 3.  Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies.

Authors:  Tonje Thorvaldsen; Lars H Lund
Journal:  Card Fail Rev       Date:  2019-02

4.  Optimal timing of same-admission orthotopic heart transplantation after left ventricular assist device implantation.

Authors:  Gunsagar Gulati; David Ouyang; Richard Ha; Dipanjan Banerjee
Journal:  World J Cardiol       Date:  2017-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.